The global adult diaper market reached a value of US$ 12.2 Billion in 2017, registering a CAGR of 8.4% during 2010-2017
Adult diapers are available in many different forms, including pads resembling sanitary napkins, child diapers, traditional underpants, etc. With the advent of technology, there have been an increase in the demand for adult diapers due to the development of easy to wear, comfortable, thin diapers with improved retention and fluid absorption abilities.
A large geriatric population coupled with the growing cases of incontinence among men and women are the major factors driving the growth of the global adult diaper market. Additionally, the escalating demand for products which are skin friendly, odour-free and offer superior absorption is anticipated to further propel the market growth across the globe.
Some of the other factors stimulating the demand for adult diapers are rapid urbanisation, surging disposable incomes, rising cases of prostate surgeries and increasing awareness regarding the importance of hygiene.
Moreover, the use of adult diapers by guards on long duties, divers under their diving suits, pilots on long flights and other long-hour workers is also bolstering the demand for adult diapers worldwide.
Looking forward, the market value is projected to reach US$ 19 Billion by 2023, expanding at a CAGR of 7.5% during 2018-2023.
Market Summary:
Based on type, the market has been segmented as pad-type, flat-type and pant-type adult diapers. Amongst these, pad-type adult diapers dominate the market, holding the largest share.
On the basis of distribution channel, pharmacies represent the largest segment, accounting for the majority of the global share. Other major distribution channels are convenience stores and online.
Region-wise, the market has been segregated into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Currently, North America is the leading market, accounting for the majority of the global share.
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will...
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring's intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring...
As Earth Day approaches on April 22, Assisted Living Locators, a nationwide senior placement and referral service, is thrilled to spotlight its inspiring partnership with One Tree Planted, an environmental non-profit tree planting charity that plant...
Zynex, Inc. , an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at...
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announces new data from the largest European real-world evidence study (PERSEUS) of Fetroja®/Fetcroja® (cefiderocol), an innovative...
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced that Denis Johnson has joined the company as its new Chief Operating Officer (COO). Denis joins Kindeva to lead global operations for all Kindeva's...